Governing prospects, navigating minefields and protecting interests: Legal issues in big data driven biotech- & biomedical innovation

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Standard

Governing prospects, navigating minefields and protecting interests : Legal issues in big data driven biotech- & biomedical innovation . / Wested, Jakob.

2018. Abstract from DCB13, Vejle, Denmark.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Harvard

Wested, J 2018, 'Governing prospects, navigating minefields and protecting interests: Legal issues in big data driven biotech- & biomedical innovation ', DCB13, Vejle, Denmark, 31/05/2018 - 01/06/2018.

APA

Wested, J. (2018). Governing prospects, navigating minefields and protecting interests: Legal issues in big data driven biotech- & biomedical innovation . Abstract from DCB13, Vejle, Denmark.

Vancouver

Wested J. Governing prospects, navigating minefields and protecting interests: Legal issues in big data driven biotech- & biomedical innovation . 2018. Abstract from DCB13, Vejle, Denmark.

Author

Wested, Jakob. / Governing prospects, navigating minefields and protecting interests : Legal issues in big data driven biotech- & biomedical innovation . Abstract from DCB13, Vejle, Denmark.

Bibtex

@conference{e0a5abe0f8654ef3bfc1febe0b231447,
title = "Governing prospects, navigating minefields and protecting interests: Legal issues in big data driven biotech- & biomedical innovation ",
abstract = "Transparency policies and the increased technological ability to gather and process large amounts of data has created new possibilities and innovation dynamics to be seized and new legal and ethical issues to be addressed in the biomedical area, where particularly overlapping legal claims are a central issue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets, regulatory data protection and the protection of personal data forms a complex legal framework applying to the data supposed to fuel big data driven biomedical advances. Two of the central issues in this landscape of rights and regulation are the problem of data aggregation and of data transparency. This presentation will focus on the role of Clinical research 2.0 in driving the development of personalized medicine as well as Orphan drugs and the legal issues arising in this context related to data protection (GDPR) as well as IPR.",
author = "Jakob Wested",
year = "2018",
month = may,
day = "31",
language = "English",
note = "DCB13 : Big Data in biotechnology ; Conference date: 31-05-2018 Through 01-06-2018",
url = "http://danishbiotechsociety.org/dcb13-june-2018/",

}

RIS

TY - ABST

T1 - Governing prospects, navigating minefields and protecting interests

T2 - DCB13

AU - Wested, Jakob

PY - 2018/5/31

Y1 - 2018/5/31

N2 - Transparency policies and the increased technological ability to gather and process large amounts of data has created new possibilities and innovation dynamics to be seized and new legal and ethical issues to be addressed in the biomedical area, where particularly overlapping legal claims are a central issue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets, regulatory data protection and the protection of personal data forms a complex legal framework applying to the data supposed to fuel big data driven biomedical advances. Two of the central issues in this landscape of rights and regulation are the problem of data aggregation and of data transparency. This presentation will focus on the role of Clinical research 2.0 in driving the development of personalized medicine as well as Orphan drugs and the legal issues arising in this context related to data protection (GDPR) as well as IPR.

AB - Transparency policies and the increased technological ability to gather and process large amounts of data has created new possibilities and innovation dynamics to be seized and new legal and ethical issues to be addressed in the biomedical area, where particularly overlapping legal claims are a central issue. Patent claims, intellectual property rights and sui generis rights for data collections, trade secrets, regulatory data protection and the protection of personal data forms a complex legal framework applying to the data supposed to fuel big data driven biomedical advances. Two of the central issues in this landscape of rights and regulation are the problem of data aggregation and of data transparency. This presentation will focus on the role of Clinical research 2.0 in driving the development of personalized medicine as well as Orphan drugs and the legal issues arising in this context related to data protection (GDPR) as well as IPR.

M3 - Conference abstract for conference

Y2 - 31 May 2018 through 1 June 2018

ER -

ID: 210111100